The influence of metabolic syndrome on acute kidney injury occurrence after coronary artery bypass grafting

Heart Surgery Forum

Volumn 19, Issue 3, 2016, Pages E99-E103

  Kunt, Atike Tekeli ^a   Parlar, Hakan ^a   Findik, Orhan ^a   Duzyol, Cagri ^a   Baris, Ozgur ^a   Balci, Canan ^a  

^a Department of Radiology   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ABDOMINAL OBESITY; ACUTE KIDNEY FAILURE; ADULT; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; COMPLICATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

ACUTE KIDNEY INJURY; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84977613792     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/hsf.1400     Document Type: Article

References (24)

1. Alberti KG, Zimmet P, Shaw J. 2005. The Metabolic Syndrome: a new worldwide definition. Lancet 366:1059-62.
2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. 2004. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204-12.
3. Carson JL, Scholz PM, Chen AY, et al. 2002. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40:418-23.
4. Chertow GM, Lazarus JM, Christiansen CL, et al. 1997. Preoperative renal risk stratification. Circulation 95:878-84.
5. Cockcroft DW, Gault MH. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
6. Despres JP. 2003. Inflammation and cardiovascular disease: is abdominal obesity the missing link? Int J Obes Metab Disord 27suppl:S22-24.
7. Doddakula K, Al-Sarraf N, Gately K, et al. 2007. Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc and Thorac Surg 6:314-18.
8. Echahidi N, Pibarot P, Despres JP, et al. 2007. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 50:843-51.
9. Glance LG, Wissler R, Mukamel DB, et al. 2010. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 113:859-72.
10. Hall RI, Smith MS, Rocker G. 1997. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85:766-82.
11. Hong S, Youn YN, Yoo KJ. 2010. Metabolic syndrome as a risk factor for postoperative kidney injury after off-pump coronary artery bypass surgery. Circ J 74:1121-6.
12. Kajimato K, Kasai T, Miyauchi K, et al. 2008. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 72:1481-6.
13. Kajimoto K, Miyauchi K, Kasai T, et al. 2009. Metabolic syndrome is an independent risk factor for stroke and acuterenal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 137:658-63.
14. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. 2001. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59:1498-1509.
15. Kurella M, Lo JC, Chertow GM. 2005. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134-40.
16. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. 2000. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11:97-104.
17. Mariam PA, Tejas VP, Youssef MK, Adriana F, Helmut GR, Ajay KS. 2009. Kidney pathological changes in metabolic syndrome: A crosssectional study. Am J Kidney Dis 53:751-9.
18. Mirmuhammad-Sadeghi M, Naghiloo A, Najarzadegan MR. 2013. Evaluating the relative frequency and predictors of acute renal failure following coronary artery bypass grafting. ARYA Atheroscler 9:287-92.
19. Pan W, Hindler K, Lee VV, Vaughn WK, Collard CD. 2006. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 104:441-7.
20. Sprecher DL, Pearce GL. 2000. How deadly is the "deadly quertet?" A post-CABG evaluation. J Am Coll Cardiol 36:1159-65.
21. Suen WS, Mok CK, Chiu SW, et al. 1998. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology 49:789-90.
22. Swart MJ, De Jager WH, Kemp JT, Nel PJ, Van Staden SL, Joubert G. 2012. The effect of the metabolic syndrome on the risk and outcome of coronary artery bypass graft surgery. Cardiovasc J Africa 23:400-4.
23. Uendo M, Kawashima S, Nishi S, et al. 1997. Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int Suppl 63:S191-4.
24. Weerasinghe A, Hornick P, Smith P, Taylor K, Ratnatunga C. 2001. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction J Thorac Cardiovasc Surg 121:1083-9.